🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.

Several professionals said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Removal

Based on the social media company, the platform has taken down problematic content and banned related keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of joining one group, a seller posted contact information, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Item Information and Costs

Within these communities, messages show black plastic parcels with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to possibly significant health risks”.